Orthofix Launches Opus BA for Spinal Surgery
Orthofix Medical commenced full market launch of Opus™ BA, a synthetic bioactive bone graft solution for cervical and lumbar spine...
Orthofix Medical commenced full market launch of Opus™ BA, a synthetic bioactive bone graft solution for cervical and lumbar spine...
This is the second Breakthrough Designation for Theradaptive in spinal fusion, granted for the OsteoAdapt SP implant....
Proposed indications include filling of bony voids and gaps, and protecting against microbial colonization while granules resorb and are replaced...
A critical component for bone development, magnesium contains high strength and a modulus of elasticity that closely resembles human bone....
This is the second-ever bone graft to achieve clearance for standalone use in the spine based on human clinical data....
Results address bone formation properties of a clinically accepted bone graft material, bioactive glass, and its optimization....
Mg OSTEOINJECT is the first injectable bone void filler in the U.S. to incorporate magnesium for bone health and development....
OssDsign will launch a U.S. clinical registry to collect real-world data on Catalyst in spinal fusion applications....
The expanded FDA clearance applies to indications for use with NuVasive's thoracolumbar spinal interbody portfolio....
NeoGenix XP more closely resembles natural bone vs. synthetic materials, such as hydroxyapatite or tricalcium phosphate....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.